Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-08

Clinical Trial Update: Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction [NA]

View source ↗

Summary

Clinical trial update indicates a completed study evaluating daily oral L-arginine plus tadalafil in diabetic patients with erectile dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arginine (L-Arginine)
  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Aswan University Hospital | Conditions: Erectile Dysfunction | NA | Status: COMPLETED